← All trials

NCT05258669

Phase 2/Phase 3Interventional

Trials that are a combination of phases 2 and 3.

View on ClinicalTrials.gov ↗

Timeline

Start date
Feb 20, 2022
Primary completion
Sep 1, 2023
Completion date
Oct 31, 2023
First posted
Feb 28, 2022
Last posted
Aug 31, 2022
Enrollment
400
Arms / groups
2 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.